Dr. Ankit Neeraj Medhekar, MD

Dr. Medhekar practices at Inova Fair Oaks Hospital in Fairfax, Virginia, part of Inova Health Care Services.

Dr. Medhekar's NPI, 1851897102, was assigned on April 4, 2018. Dr. Medhekar graduated from University of Rochester School of Medicine and Dentistry in 2018. Dr. Medhekar holds Virginia license 0101281404.

Dr. Medhekar's primary practice is Inova Fair Oaks Hospital, at 3600 Joseph Siewick Drive, Fairfax, VA 22033 in Fairfax County. The practice phone is (703) 391-4170.

Dr. Medhekar's primary practice is Inova Fair Oaks Hospital in Fairfax, Virginia, part of Inova Health Care Services. Dr. Medhekar is also affiliated with Inova Fairfax Hospital. The medical group on file is Inova Urgent Care Center. Dmand AI also links Dr. Medhekar to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Medhekar practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Medhekar's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Medhekar is licensed in Virginia.

CMS data shows 840 Medicare services from Dr. Medhekar across 12 procedure codes in 2024, for 546 Medicare patients. Medicare paid $41,551 for them.

CMS counts 546 Medicare patients who saw Dr. Medhekar in 2024. The largest group is 75 to 84, with 213 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Medhekar's median patient age at 65, with 50% women.

In 2024, Dr. Medhekar wrote 77 Medicare Part D claims for 44 patients. 95% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $343 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Medhekar for performance year 2024, reported as part of a group. Dr. Medhekar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Medhekar, published from 2016 to 2023. 2019 was the busiest year, with 2. The most frequent topics are Defibrillators, Implantable, Aortic Aneurysm, Abdominal and Death, Sudden, Cardiac. Dr. Medhekar has published most often in Clin Cardiol. Dr. Medhekar's most frequent co-authors are Sandeep Jain, MD, Sandeep Jain, MD and Samir F. Saba.

CMS Open Payments shows 65 general payments to Dr. Medhekar from 18 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 83% of the total. Abbott Laboratories paid the most, $1,441.

Dr. Medhekar graduated from University of Rochester School of Medicine and Dentistry in 2018.